0.00
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Mera Pharmaceuticals
Its shares trade under the ticker MRPI. It has been listed since 13 June 2002.
Mera Pharmaceuticals, Inc. is a marine biotechnology company. The company is headquartered in Kailua-Kona, Hawaii. The company went IPO on 2002-06-13. The firm focuses on photobioreactor technology and owns intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production. The firm manufactures natural astaxanthin from Haematococcus pluvialis microalgae. Through its research and development, the Company has formulated AstaFactor, an astaxanthin supplement with antioxidant and anti-inflammatory activity, which is available in three formulations, such as rejuvenating formula, sports formula and salmon essentials, such as natural astaxanthin combined with a blend of fish and salmon oil. The firm also produces sea salt products, such as gourmet salt and nigari. The gourmet salt includes Hawaiian Furikake, Hawaiian Furikake refillable grinder, Kona Sea Salt, Kona Sea Salt flake salt case, Kona Sea Salt grinder and Kona Sea Salt grinder case. The firm offers nigari in sizes ranging from one gallon to 250 gallons.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 13 Jun 2002
- Employees
- 4
- Website
- merapharma.com ↗
Leadership
Pay as last reported
- Mr. Benny DoroPresident, Company Secretary, Interim Director, since 2021
- Mr. Charles SpaniakChief Financial Officer, since 2012
- Mr. Rafi MarkariansTreasurer, Director, since 2021
- Joyce MarkleySecretary, Director, since 2012
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Mera Pharmaceuticals Inc has a strong reputation in the pharmaceutical industry.
- The company has a diverse range of high-quality and effective products.
- Mera Pharmaceuticals Inc has a large and loyal customer base.
- The company has a robust research and development department, allowing for continuous innovation.
- Mera Pharmaceuticals Inc has a well-established distribution network, ensuring widespread availability of its products.
Weaknesses
- Mera Pharmaceuticals Inc lacks international presence, limiting its market reach.
- The company heavily depends on a few key suppliers, making it vulnerable to supply chain disruptions.
- Mera Pharmaceuticals Inc has limited brand recognition compared to some of its competitors.
- The company faces increasing competition in the pharmaceutical industry.
- Mera Pharmaceuticals Inc has a relatively small market share in certain therapeutic areas.
Opportunities
- The growing demand for personalized medicine presents an opportunity for Mera Pharmaceuticals Inc to develop tailored products.
- Expansion into emerging markets can provide new revenue streams for the company.
- Mera Pharmaceuticals Inc can explore partnerships or acquisitions to enhance its product portfolio or enter new markets.
- Advancements in technology offer the potential for improved manufacturing processes and cost efficiencies.
- Increasing healthcare expenditure and aging populations create a favorable market environment for pharmaceutical companies.
Threats
- Stringent regulations and compliance requirements in the pharmaceutical industry pose challenges for Mera Pharmaceuticals Inc.
- The emergence of generic competitors can impact the market share and profitability of Mera Pharmaceuticals Inc.
- Intellectual property infringement or patent expirations can lead to the loss of exclusive rights for certain products.
- Changes in healthcare policies or reimbursement models may affect pricing and market access for pharmaceutical companies.
- Economic downturns can reduce consumer spending on healthcare, impacting Mera Pharmaceuticals Inc's sales.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.